Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Cyclophosphamide × 30 days × Clear all

Sponsor

Conditions

Multiple Myeloma 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 19 Lymphoma 18 Burkitt Lymphoma 18 Lymphoma, Follicular 15 Neoplasms 14 Leukemia, Myeloid, Acute 14 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Breast Neoplasms 12 Recurrence 10 Melanoma 10 Hodgkin Disease 9 Myelodysplastic Syndromes 8 Ovarian Neoplasms 7 Lymphoma, B-Cell, Marginal Zone 7 Lymphoma, B-Cell 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia, Biphenotypic, Acute 7 Leukemia 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Sarcoma 5 Rhabdomyosarcoma 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, Mantle-Cell 5 Hematologic Neoplasms 5 Sarcoma, Ewing 4 Neuroblastoma 4

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡